
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Innoblative is a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate soft tissue to achieve better care for patients. Innoblative has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the companys SIRA RFA Electrosurgical Device. The SIRA device is investigational for use in BCS and is not yet available for sale in the United States. The SIRA device is cleared for intraoperative coagulation and ablation of soft tissue
Innoblative operates in the Medical equipment manufacturing industry.
Innoblative's revenue is 11m - 100m
Innoblative has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.